Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc (CURX): 5 pipeline candidates · ~16 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
16.4 months
D/E 0.04 · 0% dilution
Lead: Approved
5 candidates
N/A
N/A
A transparent, data-derived signal for Curanex Pharmaceuticals Incacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$9.1M
Cash
$4.0M
Quarterly Burn
$955K
Runway
16.4 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| naltrexone-bupropion combination | Phase 4 |
| Phyto-N | Preclinical |
| silenor | Approved |
| silenor | Approved |
| treximet | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$168K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 111,130 | $57K |
| two sigma securities, llc | 56,651 | $29K |
| xtx topco ltd | 51,289 | $26K |
| citadel advisors llc | 50,559 | $26K |
| two sigma investments, lp | 20,254 | $10K |
| citigroup inc | 19,332 | $10K |
| jump financial, llc | 10,551 | $5K |
| ubs group ag | 7,995 | $4K |
Frequently asked questions
How many drug candidates are in Curanex Pharmaceuticals Inc's pipeline?
Curanex Pharmaceuticals Inc (CURX) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Curanex Pharmaceuticals Inc's lead drug candidate?
Curanex Pharmaceuticals Inc's most advanced tracked candidate is naltrexone-bupropion combination (Phase 4) for Obesity.
What is Curanex Pharmaceuticals Inc's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Curanex Pharmaceuticals Inc has approximately 16.4 months of cash runway.
What is Curanex Pharmaceuticals Inc's market capitalization?
Curanex Pharmaceuticals Inc's market capitalization is approximately $9.1M.
Who is the CEO of Curanex Pharmaceuticals Inc?
Mr. Jun Liu is the chief executive officer of Curanex Pharmaceuticals Inc (CURX).
Get the full picture on Curanex Pharmaceuticals Inc
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.